Letong Cai

3PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 15, 2025
Disruption of cell-intrinsic PCSK9 enhances the antitumor efficacy of CD8+ T cells.

Bing Liu, Letong Cai, Yiwen Yan

|Sep 29, 2023
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Letong Cai, Yuchen Li, Jiaxiong Tan

|Sep 05, 2023
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.

Letong Cai, Yuchen Li, Jiaxiong Tan

Pageof 1